Immunohistologic Demonstration of Platelet-derived Growth Factor (PDGF) and sis-Oncogene Expression in Scleroderma
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 92 (2) , 301-303
- https://doi.org/10.1111/1523-1747.ep12276895
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblastsBiochemical Journal, 1987
- Transforming Growth Factor-Beta: Selective Increase in Glycosaminoglycan Synthesis by Cultures of Fibroblasts From Patients With Progressive Systemic SclerosisJournal of Investigative Dermatology, 1987
- Regulation of Collagen Gene Expression in Cutaneous Diseases With Dermal Fibrosis: Evidence for Pretranslational ControlJournal of Investigative Dermatology, 1987
- Detection of oncogene‐related proteins with site‐directed monoclonal antibody probesJournal of Clinical Laboratory Analysis, 1987
- The biology of platelet-derived growth factorCell, 1986
- A significant part of macrophage-derived growth factor consists of at least two forms of PDGFCell, 1985
- Platelet-derived growth factorMolecular and Cellular Endocrinology, 1985
- Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.Proceedings of the National Academy of Sciences, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Skin thickness and collagen content in progressive systemic sclerosis and localized sclerodermaArthritis & Rheumatism, 1979